EFFICACY OF ADAPTOL IN COMPLEX THERAPY OF PATIENTS WITH PSORIATIC ARTHRITIS
According to clinical statistics from 1% to 8% of the world’s population suffer from psoriasis.Current ecological conditions witness the increase in the number of psoriatic patients with 1.5 times growth of severe psoriatic forms being resistant to traditional therapies. Difficult ecological conditions, causative agents influence and other factors complicate the development of human adaptation, thus practical use of any methods of stress system correction and elimination of functional system unbalance is considered to be a necessary and important addition to traditional methods of adaptive abilities improvement.This article explored the psycho-emotional disorders in psoriatic arthritis and assessed the feasibility and the clinical efficacy and tolerability of anxiolytic drug Adaptol ® («Olainfarm", Latvia) in the complex therapy.